A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 9, 2014

Primary Completion Date

August 28, 2017

Study Completion Date

August 28, 2017

Conditions

Advanced Solid Tumors

Interventions

DRUG

Irinotecan liposome

Trial Locations (1)

Fudan University Cancer Hospital, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05086822 - A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors | Biotech Hunter | Biotech Hunter